Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Leukemia Research
|
May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy
Chetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.
American Journal of Hematology
|
October 21, 2021
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
Amber C King, Taylor M Weis, Andriy Derkach, et al.
Leukemia & Lymphoma
|
October 14, 2024
HMA/VEN treatment modifications and associated outcomes in <i>IDH</i>-mutant AML
Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, et al.
Leukemia Research
|
September 15, 2022
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
Jan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Leukemia & Lymphoma
|
October 26, 2022
Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
Jan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Blood
|
December 9, 2022
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati, et al.
Leukemia Research
|
June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Aaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
Blood Advances
|
December 5, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
William A Wood, Donna S Neuberg, J Colton Thompson, et al.
Cancer
|
August 7, 2025
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
Hannah Burton, Leora Boussi, David Nemirovsky, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Leukemia Research
|
May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy
Chetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.
American Journal of Hematology
|
October 21, 2021
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
Amber C King, Taylor M Weis, Andriy Derkach, et al.
Leukemia & Lymphoma
|
October 14, 2024
HMA/VEN treatment modifications and associated outcomes in <i>IDH</i>-mutant AML
Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, et al.
Leukemia Research
|
September 15, 2022
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
Jan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Leukemia & Lymphoma
|
October 26, 2022
Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
Jan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Blood
|
December 9, 2022
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati, et al.
Leukemia Research
|
June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Aaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
Blood Advances
|
December 5, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
William A Wood, Donna S Neuberg, J Colton Thompson, et al.
Cancer
|
August 7, 2025
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
Hannah Burton, Leora Boussi, David Nemirovsky, et al.
Page
of 7